- Home
- NNVC vs AEON Comparison
NNVC vs AEON Comparison
Compare NNVC & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNVC | AEON |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 26.8M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | NNVC | AEON |
|---|---|---|
| Price | $0.89 | $0.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | ★ 242.3K | 63.4K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $0.38 |
| 52 Week High | $2.23 | $1.45 |
Technical Indicators
Market Signals| Indicator | NNVC | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 43.09 |
| Support Level | $0.85 | $0.69 |
| Resistance Level | $1.07 | $1.12 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 2.76 | 4.26 |
Price Performance
Historical ComparisonAbout NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.